US › Healthcare

Canopy Growth Corp (CGC)

US · Healthcare · Drug Manufacturers - Specialty & Generic

$0.93-2.76%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$71.2M
Revenue YoY
+9.6%
Net profit
$-157.1M
Profit YoY
+28.8%
EPS
$-0.17
EPS estimate
$-0.06
Net margin
-220.5%

EPS came in at -0.17 against a street estimate of -0.06 — a miss of 183.3%.

Key statistics

Market cap
$429.4M
Forward P/E
20.4
P/B
0.78
Book value
$1.18
EPS (TTM)
$-0.63
52-week high
$2.38
52-week low
$0.84
50-day MA
$0.98
200-day MA
$1.12
Beta
2.41

Analyst view

Analysts rate Canopy Growth Corp a hold (2 buy, 4 hold, 4 sell out of 10) with an average price target of $1.24.

Shareholding

Insiders
0.25%
Institutions
7.85%

Largest institutional holders

FundStake
Tidal Investments LLC.2.01%
Morgan Stanley - Brokerage Accounts0.47%
Lazard Asset Management LLC0.43%
Jane Street Group LLC0.37%
The Goldman Sachs Group Inc0.30%
Citadel Advisors Llc0.27%
Susquehanna International Group, LLP0.23%
Royal Bank of Canada0.23%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Canopy Growth Corp — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.